Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at cnbc.com →

More in Health & Medicine

More from Friday 2 October →